Molecular Partners AG

SWX:MOLN 주식 보고서

시가총액: CHF 202.1m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Molecular Partners 관리

관리 기준 확인 3/4

Molecular Partners' CEO는 Patrick Amstutz, Jan2004 에 임명되었습니다 의 임기는 20.42 년입니다. 총 연간 보상은 CHF 1.05M, 36.8% 로 구성됩니다. 36.8% 급여 및 63.2% 보너스(회사 주식 및 옵션 포함). 는 CHF 6.17M 가치에 해당하는 회사 주식의 2.22% 직접 소유합니다. 6.17M. 경영진과 이사회의 평균 재임 기간은 각각 2.9 년과 4.2 년입니다.

주요 정보

Patrick Amstutz

최고 경영자

CHF 1.0m

총 보상

CEO 급여 비율36.8%
CEO 임기20.5yrs
CEO 소유권2.2%
경영진 평균 재임 기간3yrs
이사회 평균 재임 기간4.3yrs

최근 관리 업데이트

We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation

Apr 11
We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation

Recent updates

We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation

Apr 11
We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation

Is Molecular Partners (VTX:MOLN) In A Good Position To Invest In Growth?

Jan 09
Is Molecular Partners (VTX:MOLN) In A Good Position To Invest In Growth?

Here's Why We're Watching Molecular Partners' (VTX:MOLN) Cash Burn Situation

Sep 08
Here's Why We're Watching Molecular Partners' (VTX:MOLN) Cash Burn Situation

Need To Know: The Consensus Just Cut Its Molecular Partners AG (VTX:MOLN) Estimates For 2023

Jun 23
Need To Know: The Consensus Just Cut Its Molecular Partners AG (VTX:MOLN) Estimates For 2023

What You Need To Know About The Molecular Partners AG (VTX:MOLN) Analyst Downgrade Today

Aug 31
What You Need To Know About The Molecular Partners AG (VTX:MOLN) Analyst Downgrade Today

Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

May 09
Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

Upgrade: Analysts Just Made A Substantial Increase To Their Molecular Partners AG (VTX:MOLN) Forecasts

Dec 26
Upgrade: Analysts Just Made A Substantial Increase To Their Molecular Partners AG (VTX:MOLN) Forecasts

We're Hopeful That Molecular Partners (VTX:MOLN) Will Use Its Cash Wisely

Jun 24
We're Hopeful That Molecular Partners (VTX:MOLN) Will Use Its Cash Wisely

Molecular Partners AG (VTX:MOLN) Could Be Less Than A Year Away From Profitability

Mar 09
Molecular Partners AG (VTX:MOLN) Could Be Less Than A Year Away From Profitability

Analysts Just Made A Major Revision To Their Molecular Partners AG (VTX:MOLN) Revenue Forecasts

Feb 10
Analysts Just Made A Major Revision To Their Molecular Partners AG (VTX:MOLN) Revenue Forecasts

Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

Jan 21
Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

How Much Of Molecular Partners AG (VTX:MOLN) Do Insiders Own?

Dec 17
How Much Of Molecular Partners AG (VTX:MOLN) Do Insiders Own?

Downgrade: Here's How Analysts See Molecular Partners AG (VTX:MOLN) Performing In The Near Term

Nov 21
Downgrade: Here's How Analysts See Molecular Partners AG (VTX:MOLN) Performing In The Near Term

CEO 보상 분석

Patrick Amstutz 의 보수는 Molecular Partners 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-CHF 59m

Dec 31 2023CHF 1mCHF 385k

-CHF 62m

Sep 30 2023n/an/a

-CHF 60m

Jun 30 2023n/an/a

-CHF 62m

Mar 31 2023n/an/a

-CHF 50m

Dec 31 2022CHF 1mCHF 383k

CHF 118m

Sep 30 2022n/an/a

CHF 117m

Jun 30 2022n/an/a

CHF 118m

Mar 31 2022n/an/a

CHF 106m

Dec 31 2021CHF 1mCHF 380k

-CHF 64m

Sep 30 2021n/an/a

-CHF 67m

Jun 30 2021n/an/a

-CHF 72m

Mar 31 2021n/an/a

-CHF 66m

Dec 31 2020CHF 1mCHF 380k

-CHF 63m

Sep 30 2020n/an/a

-CHF 53m

Jun 30 2020n/an/a

-CHF 48m

Mar 31 2020n/an/a

-CHF 43m

Dec 31 2019CHF 930kCHF 363k

-CHF 36m

Sep 30 2019n/an/a

-CHF 37m

Jun 30 2019n/an/a

-CHF 38m

Mar 31 2019n/an/a

-CHF 38m

Dec 31 2018CHF 909kCHF 346k

-CHF 37m

Sep 30 2018n/an/a

-CHF 27m

Jun 30 2018n/an/a

-CHF 18m

Mar 31 2018n/an/a

-CHF 24m

Dec 31 2017CHF 885kCHF 344k

-CHF 25m

보상 대 시장: Patrick 의 총 보상 ($USD 1.18M )은 Swiss 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 1.18M ).

보상과 수익: 회사가 수익성이 없는 동안 Patrick 의 보상이 증가했습니다.

CEO

Patrick Amstutz (49 yo)

20.5yrs

테뉴어

CHF 1,047,000

보상

Dr. Patrick Amstutz, Ph.D. is a Co-Founder of Molecular Partners AG and has been its Chief Executive Officer since November 2016 and serves as its Member of Management Board since 2004. Dr. Amstutz serves...

리더십 팀

이름위치테뉴어보상소유권
Patrick Amstutz
Co-Founder20.5yrsCHF 1.05m2.22%
CHF 4.5m
Michael Stumpp
Co-Founder20.5yrs데이터 없음2.31%
CHF 4.7m
Robert Hendriks
Senior VP of Finance5yrs데이터 없음데이터 없음
Alexander Zurcher
COO & Member of Management Board2yrs데이터 없음0.077%
CHF 156.6k
Renate Gloggner
Executive VP of People & Community and Member of Management Board2.6yrs데이터 없음0.069%
CHF 140.1k
Daniel Steiner
Senior Vice President of Research & Technology3.3yrs데이터 없음데이터 없음
Seth Lewis
Senior Vice President of Investor Relationsno data데이터 없음데이터 없음
Michael Pitzner
General Counsel1.7yrs데이터 없음데이터 없음
Pamela Trail
Strategic Consultant5yrs데이터 없음데이터 없음
Anne Goubier
Senior Vice President of Research & Early Development2.5yrs데이터 없음데이터 없음
Philippe Legenne
Interim Chief Medical Officerless than a year데이터 없음데이터 없음

3.0yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: MOLN 의 관리팀은 경험 ( 2.9 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Patrick Amstutz
Co-Founder6.8yrsCHF 1.05m2.22%
CHF 4.5m
Steven H. Holtzman
Independent Non Executive Director10.2yrsCHF 135.00k0.044%
CHF 89.6k
William A. Burns
Independent Chairman of the Board6.8yrsCHF 295.00k0.081%
CHF 164.1k
Vito Palombella
Independent Director4.3yrsCHF 125.00k0.011%
CHF 21.3k
Agnete Fredriksen
Independent Director3.3yrsCHF 125.00k데이터 없음
Michael Vasconcelles
Independent Director4.3yrsCHF 135.00k0.011%
CHF 21.4k
Sandip Kapadia
Independent Director4.3yrsCHF 130.00k0.011%
CHF 21.4k
Dominik Hochli
Independent Director3.3yrsCHF 133.00k데이터 없음

4.3yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 이사회: MOLN 의 이사회는 경험(평균 재직 기간 4.2 년)으로 간주됩니다.